This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Gelteq centers its technology on a proprietary, customizable gel platform designed for precise drugdelivery, supporting prescription drugs, nutraceuticals, pet care and sports supplements. Priced at $4.0
From the Human Genome Project to contemporary drug development, collaboration is critical to the lifesciences. It is also an important factor in the success of lifesciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.
Ireland-based Fountain Healthcare Partners has raised another €125 million ($131 million) for its third lifesciences fund – 25% ahead of its target – and says it will pump most of the money into European therapeutics and medical device companies. The third fund is now closed.
Additionally, a collaboration with NurExone is creating an intranasal delivery system for exosome-based therapies targeting spinal cord injuries, with potential expansion into other neurological uses. Polyrizon’s focus on intranasal protection aligns with a rapidly expanding market in drugdelivery innovation.
Highlights include expansion of biotech operations in Philadelphia, acquisition of a new pharma-device facility near Dublin, Ireland, and a new Center of Excellence for advanced drugdelivery and drug-device combination product assembly in Rockford, Illinois.
As Chief Medical and Scientific Officer at Click Therapeutics and a Board Director at SpineThera, he spearheads AI-enabled clinical development and drug-delivery platforms. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
TriSalus LifeSciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of SD-101 via Pressure-Enabled DrugDelivery in Uveal Melanoma Liver Metastases TriSalus LifeSciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of … Continue reading →
The team also learned about the FDA approval of Genentech’s new ocular implant drugdelivery system, called Susvimo, for the treatment of neovascular, or wet, age-related macular degeneration (nAMD). Genentech’s New Ocular Implant DrugDelivery System for Macular Degeneration Could Be a Game Changer.
Employee retention and motivation is a challenge that all lifescience companies face. Lifescience companies often have to follow a complex regulatory framework that is associated with high risks, which is why maintaining corporate compliance is essential. Training and Development Opportunities.
For the Sarclisa ® subcutaneous formulation delivery, Sanofi has partnered with drugdelivery technology innovator company Enable Injections , Inc. to advance the development of a subcutaneous delivery for Sarclisa ® with the goal of offering a unique patient-centric treatment experience. About Blackstone LifeSciences.
Subscribe to the Xtalks LifeScience Podcast to never miss a new episode. AstraZeneca’s Airsupra Approved as First-In-Class Combo Asthma Treatment. The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.
SHL Medical is a world-leading solutions provider for advanced drugdelivery systems with a unified purpose to further enable patient independence. As it establishes these new operations, SHL Medical will be welcomed into a growing community of lifesciences companies expanding in and around Charleston.
Hayley Crowe is executive vice president and general manager of Ecolabâs Global LifeSciences sector, comprised of Ecolabâs Purolite and pharma / personal care businesses.
This extension will further help connect life-science innovators in Victoria to accelerate their healthcare solutions across the globe,” said Stacy Feld, Regional Head, Johnson & Johnson Innovation LLC, West North America, Australia & New Zealand.
When combined with mRNA therapeutic molecules developed by LG Chem, the pre-made drugdelivery formulation helps to simplify and improve the combination process. This is expected to shorten the development time of new drugs and to support personalised treatments.
A representative from the small-molecule solutions company explains how the ever-increasing mountain of life-sciences data has impacted drug development.
“By offering all-in-one solutions, including drugdelivery connected devices, digital therapeutics, and care services, we aim to reduce existing gaps in healthcare by empowering patients, improving treatment adherence, and strengthening the patient and care team relationship,” said Touya.
In this interview, Xtalks spoke with two industry experts from Alira Health , Giulia Pierini , Principal of Patient Engagement, and Eduardo Perez-Guagnelli , PhD, Patient-Centric Co-Design Lead, about how lifesciences companies can adopt patient-centric co-design in their product development.
XTALKS : Changes are Coming to Prefilled Injectable DrugDelivery Systems Live and On-Demand: Thursday, September 12, 2024, at 1pm EDT (10 am PDT) Register for this webinar today to learn more about the future of injectable drugdelivery systems and the impact of blow-fill-seal technology.
XTALKS WEBINAR: Changes are Coming to Prefilled Injectable DrugDelivery Systems Live and On-Demand: Thursday, September 12, 2024, at 1pm EDT (10am PDT) Register for this webinar today to learn more about the future of injectable drugdelivery systems and the impact of blow-fill-seal technology.
XTALKS WEBINAR: Enhancing Distributed Manufacturing and Vaccine Distribution through Blow-Fill-Seal Prefilled DrugDelivery Platforms Live and On-Demand: Thursday, February 27, 2025, at 1pm EST (10am PST) Register for this free webinar to learn critical considerations for improving global vaccine and healthcare delivery and outcomes.
The rankings are based on each companys ability to tackle critical challenges from drugdelivery and diagnostics to personalized therapies using cutting-edge science. Here we spotlight the top 20 most innovative pharma and biotech companies of 2025 from their 2025 list that are transforming health care.
However, several drugdelivery devices that enable patients to self-administer their respective medications are now available. Biologics have emerged as a direct consequence of the rapid development that has taken place in the field of lifesciences, particularly in cell and molecular biology, over the past few decades.
XTALKS WEBINAR: DrugDelivery — Evaluating Off-The-Shelf and Novel DrugDelivery Solutions Live and On-Demand: Tuesday, July 11, 2023, at 1pm EDT (10am PDT) Register for this free webinar to learn about important tradeoffs when considering an off-the-shelf (OTS) drugdelivery platform vs. novel development.
Sanofi has agreed a deal with lifesciences investor Blackstone to help fund clinical trials of a new formulation of Sarclisa for blood cancer multiple myeloma, accelerating its development. Sanofi has partnered with drugdelivery specialist Enable Injections to develop the subcutaneous formulation.
One of the biggest challenges with developing therapies to treat CNS disorders is the delivery of systemically administered investigational products (IPs) to the brain, which is limited by the blood-brain barrier. Some methods of direct CNS administration include intrathecal, intraparenchymal and intracerebroventricular (ICV) delivery.
The two venerable Indiana institutions – Lilly headquartered in Indianapolis and Purdue in nearby West Lafayette – have been working together for many years, collaborating on lifesciences research in areas such as new delivery systems for injectable medicines and predictive models for clinical research.
Uncover advances in CNS gene therapy , new generation vectors for intravenous delivery, and the challenges of scaling up for CNS delivery beyond highly specialized centers. The high concentration of scientists who face similar challenges makes this Summit so essential to the development of the field.
For healthcare and lifesciences industries, Skin Cancer Awareness Month helps highlight the importance of preventive measures and early detection. is a biotech and lifesciences company dedicated to advancing the clinical development of innovative and groundbreaking therapeutic assets.
Highly experienced lifesciences executive that brings large pharma and biotech experience. John will be joining the Board as the representative for Oxford Sciences Innovation (OSI), one of the Company’s major shareholders. OXFORD, England , Jan.
The lifesciences unit of Google parent Alphabet – which raised $1 billion back in September to fund its precision health agenda and business development activities, including possible acquisitions – said the move would allow it to streamline its operations.
The most common side effects in the first season included injection site pain, fatigue, muscle aches, headache and joint pain, generally mild to moderate and resolving within a few days. No new safety issues emerged over the course of the three seasons.
RELATED: Walgreens, CVS, Amazon and Walmart Compete in Prescription DrugDelivery Factors Behind the CVS Health Clinical Trial Services Closure Speculations are rife in the industry for reasons behind the closure of CVS Health Clinical Trial Services.
Related: Genentech’s New Ocular Implant DrugDelivery System for Macular Degeneration Could Be a Game Changer. Vuity’s formula is fast-acting, working as quickly as 15 minutes after administration and lasting for up to six hours. Importantly, it improves near and intermediate vision without affecting distance vision.
Excipients can take many forms, such as bulking agents, binders, coatings and colourants, and they are chosen based on their ability to aid in drugdelivery, administration and even in pill identification and prevention of counterfeiting.
Drug-eluting stents (DES): DES reduce the incidence of restenosis and are coated with drugs that inhibit scar tissue growth. DCBs: DCBs, such as the Agent DCB, combine mechanical widening of the artery with drugdelivery to the vessel wall to prevent cell proliferation.
LillyDirect Pharmacy Solutions, Eli Lilly’s direct-to-consumer (DTC) drugs website, is teaming up with Amazon Pharmacy to deliver select medications to people’s homes. The drugs include Lilly’s newly approved GLP-1 obesity drug Zepbound (tirzepatide), around a dozen of the company’s insulins and migraine drug Emgality (galcanezumab).
CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (“ XPhyto ” or the “ Company “) is pleased to announce its drug formulation and delivery business strategy and milestones for 2021. Vektor will begin planning and development work for the incorporation of various psychedelic compounds into its drug formulations.
Starpharma experimenting with Gilead’s antiviral drug for easier administration. Melbourne-based Starpharma has announced it has applied its novel DEP drugdelivery technology to create a long ? This week’s round up dives into developments from companies based in Australia and the US. acting, water-soluble version of remdesivir.
Ocrevus Zunovo uses Halozyme Therapeutics’ Enhanze drugdelivery technology , which enhances absorption by temporarily increasing the permeability of the subcutaneous tissue. The enzyme rHuPH20 enables rapid dispersion of the drug into the bloodstream.
The US Food and Drug Administration (FDA) granted approval to AstraZeneca’s Airsupra (albuterol/budesonide), formerly known as PT027, for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of asthma attacks in individuals aged 18 years and older who have asthma.
These innovative instruments combine precision, convenience, and patient-centered design to revolutionize drugdelivery. These devices are equipped with advanced features like programmable dosing, connectivity to mobile apps, and safety mechanisms to ensure accurate and controlled drugdelivery.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content